• Brigit Biofarmaka Teknologi's assets rose 32.42% to IDR 173.48 billion as of September 30, 2026.
• Assets totaled IDR 131 billion on December 31, 2025.
• The increase reflected IDR 28.13 billion in additional working capital from warrant exercises on January 12, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PT Brigit Biofarmaka Teknologi Tbk published the original content used to generate this news brief via Indonesia Stock Exchange (IDX) (Ref. ID: 047/X/PR/2026) on October 30, 2026, and is solely responsible for the information contained therein.